{"entity":{"type":"insider","cik":"0001914164","url":"/insider/0001914164","json_url":"/insider/0001914164.json","name":"Atkinson Edward Morrow III","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":14,"first":"2023-03-03","last":"2026-02-26","span_basis":"filed_date"},"name_variants":[{"name":"Atkinson Edward Morrow III","source":"filing","n_filings":14,"first_seen":"2023-03-03","last_seen":"2026-02-26"}],"transactions":[{"id":5854758,"accession":"0000875320-26-000106","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-26-000106","line_url":"/filing/0000875320-26-000106#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001914164","owner_name":"Atkinson Edward Morrow III","owner_display_name":"Atkinson Edward Morrow III","owner_url":"/insider/0001914164","role":"Officer (EVP, Chief Technical Ops. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Ops. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Ops. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":668.0,"shares_display":"668","price_per_share":486.35,"price_display":"486.35","price_state":"stated","total_value":324881.8,"total_display":"324,881.80","total_whole":"324,882","shares_owned_after":18432.0,"shares_owned_after_display":"18,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-26","scope":"insider"},{"id":6051393,"accession":"0000875320-26-000082","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000875320-26-000082","line_url":"/filing/0000875320-26-000082#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001914164","owner_name":"Atkinson Edward Morrow III","owner_display_name":"Atkinson Edward Morrow III","owner_url":"/insider/0001914164","role":"Officer (EVP, Chief Technical Ops. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Ops. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Ops. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":817.0,"shares_display":"817","price_per_share":473.68,"price_display":"473.68","price_state":"stated","total_value":386996.56,"total_display":"386,996.56","total_whole":"386,997","shares_owned_after":20727.0,"shares_owned_after_display":"20,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-19","scope":"insider"},{"id":6051390,"accession":"0000875320-26-000082","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000875320-26-000082","line_url":"/filing/0000875320-26-000082#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001914164","owner_name":"Atkinson Edward Morrow III","owner_display_name":"Atkinson Edward Morrow III","owner_url":"/insider/0001914164","role":"Officer (EVP, Chief Technical Ops. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Ops. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Ops. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2031.0,"shares_display":"2,031","price_per_share":489.46,"price_display":"489.46","price_state":"stated","total_value":994093.26,"total_display":"994,093.26","total_whole":"994,093","shares_owned_after":21544.0,"shares_owned_after_display":"21,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-19","scope":"insider"},{"id":6124221,"accession":"0000875320-26-000038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-26-000038","line_url":"/filing/0000875320-26-000038#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001914164","owner_name":"Atkinson Edward Morrow III","owner_display_name":"Atkinson Edward Morrow III","owner_url":"/insider/0001914164","role":"Officer (EVP, Chief Technical Ops. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Ops. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Ops. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1751.0,"shares_display":"1,751","price_per_share":460.43,"price_display":"460.43","price_state":"stated","total_value":806212.93,"total_display":"806,212.93","total_whole":"806,213","shares_owned_after":22046.0,"shares_owned_after_display":"22,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-12","scope":"insider"},{"id":4903619,"accession":"0000875320-25-000236","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-25-000236","line_url":"/filing/0000875320-25-000236#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001914164","owner_name":"Atkinson Edward Morrow III","owner_display_name":"Atkinson Edward Morrow III","owner_url":"/insider/0001914164","role":"Officer (EVP, Chief Technical Ops. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Ops. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Ops. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":434.58,"price_display":"434.58","price_state":"stated","total_value":1086450.0,"total_display":"1,086,450.00","total_whole":"1,086,450","shares_owned_after":16852.0,"shares_owned_after_display":"16,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-19","scope":"insider"},{"id":4261189,"accession":"0000875320-25-000127","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000127","line_url":"/filing/0000875320-25-000127#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001914164","owner_name":"Atkinson Edward Morrow III","owner_display_name":"Atkinson Edward Morrow III","owner_url":"/insider/0001914164","role":"Officer (EVP, Chief Technical Ops. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Ops. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Ops. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2650.0,"shares_display":"2,650","price_per_share":475.34,"price_display":"475.34","price_state":"stated","total_value":1259651.0,"total_display":"1,259,651.00","total_whole":"1,259,651","shares_owned_after":19352.0,"shares_owned_after_display":"19,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-02-28","scope":"insider"},{"id":4336611,"accession":"0000875320-25-000107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000107","line_url":"/filing/0000875320-25-000107#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001914164","owner_name":"Atkinson Edward Morrow III","owner_display_name":"Atkinson Edward Morrow III","owner_url":"/insider/0001914164","role":"Officer (EVP, Chief Technical Ops. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Ops. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Ops. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1767.0,"shares_display":"1,767","price_per_share":480.95,"price_display":"480.95","price_state":"stated","total_value":849838.65,"total_display":"849,838.65","total_whole":"849,839","shares_owned_after":24484.0,"shares_owned_after_display":"24,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-25","filed_date":"2025-02-26","scope":"insider"},{"id":4903590,"accession":"0000875320-25-000037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000037","line_url":"/filing/0000875320-25-000037#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001914164","owner_name":"Atkinson Edward Morrow III","owner_display_name":"Atkinson Edward Morrow III","owner_url":"/insider/0001914164","role":"Officer (EVP, Chief Technical Ops. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Ops. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Ops. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1747.0,"shares_display":"1,747","price_per_share":459.83,"price_display":"459.83","price_state":"stated","total_value":803323.01,"total_display":"803,323.01","total_whole":"803,323","shares_owned_after":23225.0,"shares_owned_after_display":"23,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-11","filed_date":"2025-02-12","scope":"insider"},{"id":2078459,"accession":"0000875320-24-000174","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000174","line_url":"/filing/0000875320-24-000174#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001914164","owner_name":"Atkinson Edward Morrow III","owner_display_name":"Atkinson Edward Morrow III","owner_url":"/insider/0001914164","role":"Officer (EVP, Chief Technical Ops. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Ops. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Ops. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7288.0,"shares_display":"7,288","price_per_share":478.0,"price_display":"478.00","price_state":"stated","total_value":3483664.0,"total_display":"3,483,664.00","total_whole":"3,483,664","shares_owned_after":15972.0,"shares_owned_after_display":"15,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-12","filed_date":"2024-06-13","scope":"insider"},{"id":2078453,"accession":"0000875320-24-000101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000101","line_url":"/filing/0000875320-24-000101#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001914164","owner_name":"Atkinson Edward Morrow III","owner_display_name":"Atkinson Edward Morrow III","owner_url":"/insider/0001914164","role":"Officer (EVP, Chief Technical Ops. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Ops. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Ops. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":883.0,"shares_display":"883","price_per_share":425.7,"price_display":"425.70","price_state":"stated","total_value":375893.1,"total_display":"375,893.10","total_whole":"375,893","shares_owned_after":15972.0,"shares_owned_after_display":"15,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-27","scope":"insider"},{"id":2670766,"accession":"0000875320-24-000089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000089","line_url":"/filing/0000875320-24-000089#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001914164","owner_name":"Atkinson Edward Morrow III","owner_display_name":"Atkinson Edward Morrow III","owner_url":"/insider/0001914164","role":"Officer (EVP, Chief Technical Ops. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Ops. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Ops. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1201.0,"shares_display":"1,201","price_per_share":421.77,"price_display":"421.77","price_state":"stated","total_value":506545.77,"total_display":"506,545.77","total_whole":"506,546","shares_owned_after":18509.0,"shares_owned_after_display":"18,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-21","filed_date":"2024-02-23","scope":"insider"},{"id":2975214,"accession":"0000875320-24-000070","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000875320-24-000070","line_url":"/filing/0000875320-24-000070#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001914164","owner_name":"Atkinson Edward Morrow III","owner_display_name":"Atkinson Edward Morrow III","owner_url":"/insider/0001914164","role":"Officer (EVP, Chief Technical Ops. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Ops. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Ops. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":801.0,"shares_display":"801","price_per_share":420.79,"price_display":"420.79","price_state":"stated","total_value":337052.79,"total_display":"337,052.79","total_whole":"337,053","shares_owned_after":19710.0,"shares_owned_after_display":"19,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-21","scope":"insider"},{"id":2078447,"accession":"0000875320-24-000045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000045","line_url":"/filing/0000875320-24-000045#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001914164","owner_name":"Atkinson Edward Morrow III","owner_display_name":"Atkinson Edward Morrow III","owner_url":"/insider/0001914164","role":"Officer (EVP, Chief Technical Ops. Off)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Ops. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Ops. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":913.0,"shares_display":"913","price_per_share":420.24,"price_display":"420.24","price_state":"stated","total_value":383679.12,"total_display":"383,679.12","total_whole":"383,679","shares_owned_after":23137.0,"shares_owned_after_display":"23,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-13","scope":"insider"},{"id":8310738,"accession":"0000950170-23-026422","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-026422","line_url":"/filing/0000950170-23-026422#line-2","is_derivative":false,"issuer_cik":"0001785173","issuer_name":"89bio, Inc.","issuer_ticker":"ETNB","issuer_name_source":null,"issuer_url":"/issuer/0001785173","owner_cik":"0001914164","owner_name":"Atkinson Edward Morrow III","owner_display_name":"Atkinson Edward Morrow III","owner_url":"/insider/0001914164","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6250.0,"shares_display":"6,250","price_per_share":17.91,"price_display":"17.91","price_state":"stated","total_value":111937.5,"total_display":"111,937.50","total_whole":"111,938","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-05","scope":"insider"},{"id":8527980,"accession":"0000899243-23-007032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-007032","line_url":"/filing/0000899243-23-007032#line-2","is_derivative":false,"issuer_cik":"0001785173","issuer_name":"89bio, Inc.","issuer_ticker":"ETNB","issuer_name_source":null,"issuer_url":"/issuer/0001785173","owner_cik":"0001914164","owner_name":"Atkinson Edward Morrow III","owner_display_name":"Atkinson Edward Morrow III","owner_url":"/insider/0001914164","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":13.6,"price_display":"13.60","price_state":"stated","total_value":136000.0,"total_display":"136,000.00","total_whole":"136,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (EVP, Chief Technical Ops. Off)","n_filings":12,"first_seen":"2024-02-13","last_seen":"2026-02-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001785173","name":"89bio, Inc.","url":"/issuer/0001785173","role":"Director","n_filings":2,"first_seen":"2023-03-03","last_seen":"2023-06-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001914164","retrieved_at":"2026-08-26T09:33:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}